APTIMA
Device
Gen-Probe, Inc.
Total Payments
$8.9M
Transactions
31,773
Doctors
21,148
Companies
6
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1.7M | 12,408 | 10,003 |
| 2023 | $6.6M | 8,996 | 7,020 |
| 2022 | $319,123 | 6,226 | 5,148 |
| 2021 | $172,237 | 4,099 | 3,580 |
| 2020 | $1,583 | 14 | 12 |
| 2019 | $4,567 | 4 | 3 |
| 2018 | $3,319 | 12 | 12 |
| 2017 | $1,211 | 14 | 14 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $6.5M | 281 | 73.1% |
| Consulting Fee | $1.3M | 241 | 14.9% |
| Food and Beverage | $800,003 | 30,646 | 9.0% |
| Travel and Lodging | $223,512 | 586 | 2.5% |
| Honoraria | $45,542 | 18 | 0.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,200 | 1 | 0.0% |
Payments by Type
Research
$6.5M
281 transactions
General
$2.4M
31,492 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A10940-SC2/FluP-CSP-02 | Gen-Probe, Inc. | $4.8M | 0 |
| Year 3: Surveillance for Mycoplasma genitalium in US Sexually Transmitted Disease (STD) Clinics | Gen-Probe, Inc. | $695,716 | 0 |
| 655-A10940-001 | Gen-Probe, Inc. | $299,086 | 0 |
| 670-P10936-001 | Gen-Probe, Inc. | $195,404 | 0 |
| A10960-SC2P-CSP-01 / A10960-SC2P-CSP-02 | Gen-Probe, Inc. | $147,509 | 0 |
| 655-A10960-001 | Gen-Probe, Inc. | $109,553 | 0 |
| The association of Mycoplasma genitalium and adverse perinatal outcomes in high-risk pregnant women | Gen-Probe, Inc. | $83,347 | 0 |
| Evaluation of the Aptima CMV Quant Assay in Plasma and Non-plasma samples | Gen-Probe, Inc. | $75,000 | 0 |
| TTIMS, HIV RNA in whole blood compared to plasma as reservoir parameter, EQAPOL, Replicate Aptima HIV assay testing, Biomarkers predicting time to viral rebound, | Gen-Probe, Inc. | $36,309 | 0 |
| Validation of Hologic-Developed Analyte Specific Reagents (ASR) for Detection of Genetic Markers of Macrolide Resistance in Mycoplasma genitalium | Gen-Probe, Inc. | $31,053 | 0 |
| Year 2: Surveillance for Mycoplasma genitalium in US Sexually Transmitted Disease (STD) Clinics | Gen-Probe, Inc. | $19,004 | 0 |
| TTIMS - Transfusion Transmissible Infection Monitoring System, HIV RNA in whole blood compared to plasma as reservoir parameter, EQAPOL, Replicate Aptima HIV assay testing, Biomarkers predicting time to viral rebound, | Gen-Probe, Inc. | $7,500 | 0 |
| A10810-ATVPS-CSP | Gen-Probe, Inc. | $1,800 | 0 |
Top Doctors Receiving Payments for APTIMA — Page 4
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Medical Oncology | New York, NY | $704.36 | 2 |
| , M.D | Anatomic Pathology & Clinical Pathology | Springfield, MO | $699.19 | 4 |
| , MD | Obstetrics & Gynecology | Ponce, PR | $696.92 | 8 |
| , M.D | Facial Plastic Surgery | Boston, MA | $685.83 | 4 |
| , M.D. PHD | Hematology & Oncology | Seattle, WA | $680.69 | 2 |
| , M.D | Specialist | Ponce, PR | $680.49 | 12 |
| , M.D | Anatomic Pathology & Clinical Pathology | Reno, NV | $674.58 | 4 |
| , M.D | Clinical Pathology/Laboratory Medicine | Gainesville, FL | $659.99 | 5 |
| , M.D | Obstetrics & Gynecology | Las Vegas, NV | $647.72 | 4 |
| , MD | Obstetrics & Gynecology | Baltimore, MD | $634.41 | 5 |
| , N.P | Adult Health | New York, NY | $597.52 | 2 |
| , FNP-C | Hematology & Oncology | Beverly Hills, CA | $592.12 | 1 |
| , MD | Gynecologic Oncology | Philadelphia, PA | $582.50 | 3 |
| , MD SCD | Nephrology | Boston, MA | $582.49 | 3 |
| , MD | Hematology & Oncology | Orlando, FL | $530.31 | 3 |
| , MD, PHD | Internal Medicine | San Diego, CA | $522.16 | 2 |
| , RN, MS, NP | Women's Health | Mountain View, CA | $503.94 | 5 |
| , APRN | Family | Jacksonville, FL | $481.58 | 13 |
| , DOCTOR OF MEDICINE | Student in an Organized Health Care Education/Training Program | San Juan, PR | $473.86 | 5 |
| , APRN | Women's Health | London, KY | $466.51 | 5 |
| , WHNP-BC | Women's Health | New York, NY | $451.67 | 5 |
| , MD | Family Medicine | New York, NY | $395.59 | 3 |
| , MD | Internal Medicine | Murray, UT | $379.72 | 4 |
| , MD | Obstetrics & Gynecology | Coamo, PR | $370.57 | 3 |
| , CNM | Advanced Practice Midwife | Long Beach, CA | $360.75 | 3 |
Ad
Manufacturing Companies
- Gen-Probe, Inc. $7.8M
- Hologic Sales and Service, LLC $700,808
- Hologic, LLC $188,000
- Gen-Probe Sales & Service, Inc. $75,878
- HOLOGIC INC $44,950
- Cytyc Prenatal Products Corp. $8,000
Product Information
- Type Device
- Total Payments $8.9M
- Total Doctors 21,148
- Transactions 31,773
About APTIMA
APTIMA is a device associated with $8.9M in payments to 21,148 healthcare providers, recorded across 31,773 transactions in the CMS Open Payments database. The primary manufacturer is Gen-Probe, Inc..
Payment data is available from 2017 to 2024. In 2024, $1.7M was paid across 12,408 transactions to 10,003 doctors.
The most common payment nature for APTIMA is "Unspecified" ($6.5M, 73.1% of total).
APTIMA is associated with 13 research studies, including "A10940-SC2/FluP-CSP-02" ($4.8M).